{"id":14584,"date":"2022-08-10T17:09:56","date_gmt":"2022-08-10T16:09:56","guid":{"rendered":"https:\/\/touchrespiratory.com\/?post_type=media_gallery&p=14584"},"modified":"2022-08-10T17:09:56","modified_gmt":"2022-08-10T16:09:56","slug":"gustavo-heresi-pha-2022-chronic-thromboembolic-pulmonary-hypertension","status":"publish","type":"media_gallery","link":"https:\/\/touchrespiratory.com\/pulmonary-hypertension\/conference-hub\/gustavo-heresi-pha-2022-chronic-thromboembolic-pulmonary-hypertension\/","title":{"rendered":"Gustavo Heresi, PHA 2022: Chronic Thromboembolic Pulmonary Hypertension"},"content":{"rendered":"

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive form of pulmonary hypertension (PH) caused by blood clots that don\u2019t dissolve in the lungs. These clots cause scar-like tissue that clogs up or narrows the small blood vessels in the lungs. The characteristics and challenges of diagnosing CTPEH are discussed in this touchRESPIRATORY interview with\u00a0Dr <\/strong>Gustavo Heresi\u00a0<\/strong>(Cleveland Clinic, Cleveland, OH, USA) as well as what can be done to overcome these diagnostic challenges.<\/p>\n

The presentation titled ‘CTEPH – Overview and Treatments’ was presented at the Pulmonary Hypertension Association<\/a>, June 10-12, 2022<\/p>\n

Questions<\/b><\/p>\n

    \n
  1. What are the characteristic features of\u00a0chronic thromboembolic pulmonary hypertension (CTEPH) and how does it differ from other forms of PH?<\/li>\n
  2. What are the challenges of diagnosing CTPEH and how can they be overcome?<\/li>\n<\/ol>\n

    Disclosures:<\/b> Gustavo Heresi discloses grant\/research support from Bayer Healthcare.<\/p>\n

    Support:<\/b> Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.<\/p>\n

    Filmed in coverage of the PHA Hybrid Congress 2022.<\/i><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive form of pulmonary hypertension (PH) caused by blood clots that don\u2019t dissolve in the lungs. These clots cause scar-like tissue that clogs up or narrows the small blood vessels in the lungs. The characteristics and challenges of diagnosing CTPEH are discussed in this touchRESPIRATORY interview […]<\/p>\n","protected":false},"featured_media":14653,"template":"","class_list":["post-14584","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-pulmonary-hypertension"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":4,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14584\/revisions"}],"predecessor-version":[{"id":15321,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/14584\/revisions\/15321"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media\/14653"}],"wp:attachment":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media?parent=14584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}